Abstract B140: Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: Analysis of data on the current use of HD IL-2


Journal Article

Full Text

Duke Authors

Cited Authors

  • Wong, MKK; Morse, MA; McDermott, DF; Clark, JI; Kaufman, HL; Daniels, GA; Hua, H; Aung, S

Published Date

  • January 2016

Published In

  • Trials in Progress

Published By

Digital Object Identifier (DOI)

  • 10.1158/2326-6074.cricimteatiaacr15-b140